New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 15, 2014
09:23 EDTBSX, COV, EW, STJ, NUVA, IART, SYK, ZMHBarclays medical supplies/devices analysts hold analyst/industry conference call
Medical Supplies & Devices Analysts provide a review of the recently held Barclay's Medtech Symposium on an Analyst/Industry conference call. Relevant companies COV, BSX, STJ, MDT, EW, NUVA, IART, SYK and ZMH may be discussed on the Analyst/Industry conference call to be held on April 15 at 10:30 am.
News For BSX;COV;EW;STJ;NUVA;IART;SYK;ZMH From The Last 14 Days
Check below for free stories on BSX;COV;EW;STJ;NUVA;IART;SYK;ZMH the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
July 23, 2014
07:45 EDTSTJSt. Jude Medical management to meet with Deutsche Bank
Subscribe for More Information
06:45 EDTCOVLawmakers divided on inversion deals, NY Times says
Subscribe for More Information
July 22, 2014
08:36 EDTSYKStryker appoints CEO Kevin Lobo as chairman
Subscribe for More Information
08:25 EDTBSXBoston Scientific risk/reward favorable into Q2 results, says RBC Capital
Subscribe for More Information
08:15 EDTZMHZimmer should be bought on any weakness from Q2 results, says RBC Capital
RBC Capital believes that consensus Q2 recon estimates for Zimmer may be "a bit optimistic," but the firm thinks that investors already partially anticipate a miss on that metric The firm recommends buying the stock on any weakness associated with Q2 results, as it thinks the company's valuation is favorable, given its growth outlook. RBC Capital keeps a $120 price target and Outperform rating on the shares.
08:02 EDTSTJSt. Jude announces FlexAbility Ablation Catheter CE Mark approval, first use
St. Jude Medical CE Mark approval and first use of the FlexAbility Ablation Catheter. Designed with feedback from physician thought-leaders around the world, the FlexAbility catheter combines a unique, irrigated flexible catheter tip with a state-of-the-art handle and catheter design. The next-generation flexible tip technology was designed to reduce complications associated with ablation procedures through its ability to bend and conform to the cardiac anatomy, decreasing the amount of pressure distributed to a patientís heart wall while simultaneously increasing the stability of therapy delivery.
07:57 EDTEWHouse Energy & Commerce Committee to hold a hearing
The Subcommittee on Health holds a hearing entitled, "21st Century Cures: Examining Barriers to Ongoing Evidence Development and Communication" with CEO Mussallem at Edwards Lifesciences on July 22 at 3 pm. Webcast Link
07:07 EDTCOVCovidien names Bryan Hanson as group president, effective October 1
Subscribe for More Information
July 21, 2014
16:38 EDTBSXBoston Scientific receives FDA approval for REBEL Platinum Stent system
Subscribe for More Information
08:16 EDTCOVDeutsche Bank analysts hold an analyst/industry conference call
Subscribe for More Information
July 18, 2014
12:51 EDTCOVKey GOP senator signals readiness for inversion deal, The Hill says
Subscribe for More Information
11:34 EDTCOVOptions with increasing implied volatility
Subscribe for More Information
09:00 EDTSYKStryker price target raised to $92 from $87 at RW Baird
Baird raised its price target on Stryker to $92 from $87 citing valuation, organic sales growth, and solid risk/reward. The firm has an Outperform rating on the stock.
July 17, 2014
16:09 EDTSYKStryker sees Q3 adjusted EPS $1.12-$1.16 , consensus $1.16
"If foreign currency exchange rates hold near current levels, we do not expect the impact on third quarter or full year net sales to be significant," the company said.
16:08 EDTSYKStryker sees FY14 adjusted EPS $4.75-$4.80, consensus $4.80
Now projecting full year organic sales growth to be in the range of 5.0%-6.0%, consensus $9.61B.
16:07 EDTSYKStryker reports Q2 adjusted EPS $1.08, consensus $1.08
Subscribe for More Information
15:26 EDTSYKNotable companies reporting after market close
Subscribe for More Information
11:23 EDTCOVOptions with increasing implied volatility
Subscribe for More Information
10:00 EDTCOVOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: 21st Century Fox (FOXA) downgraded to Buy from Strong Buy at ISI Group... Charter (CHTR) downgraded to Hold from Buy at Jefferies... Covidien (COV) downgraded to Hold from Buy at Needham... Diageo (DEO) downgraded to Underweight from Neutral at JPMorgan... GNC Holdings (GNC) downgraded to Hold from Buy at Jefferies... International Game (IGT) downgraded to Market Perform from Outperform at BMO Capital... JAVELIN Mortgage (JMI) downgraded to Market Perform from Outperform at JMP Securities... Macquarie Group (MQBKY) downgraded to Underweight from Neutral at JPMorgan... PNC Financial (PNC) downgraded to Neutral from Buy at Compass Point... PetSmart (PETM) downgraded to Sector Perform from Outperform at RBC Capital... Rexam (REXMY) downgraded to Hold from Buy at Deutsche Bank.
06:41 EDTCOVCovidien downgraded to Hold from Buy at Needham
Subscribe for More Information
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use